全文获取类型
收费全文 | 11170篇 |
免费 | 530篇 |
国内免费 | 91篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 218篇 |
妇产科学 | 100篇 |
基础医学 | 1216篇 |
口腔科学 | 167篇 |
临床医学 | 604篇 |
内科学 | 3170篇 |
皮肤病学 | 223篇 |
神经病学 | 758篇 |
特种医学 | 372篇 |
外科学 | 2439篇 |
综合类 | 70篇 |
预防医学 | 242篇 |
眼科学 | 123篇 |
药学 | 552篇 |
中国医学 | 27篇 |
肿瘤学 | 1405篇 |
出版年
2023年 | 92篇 |
2022年 | 177篇 |
2021年 | 303篇 |
2020年 | 137篇 |
2019年 | 209篇 |
2018年 | 248篇 |
2017年 | 224篇 |
2016年 | 268篇 |
2015年 | 291篇 |
2014年 | 403篇 |
2013年 | 444篇 |
2012年 | 812篇 |
2011年 | 834篇 |
2010年 | 442篇 |
2009年 | 411篇 |
2008年 | 690篇 |
2007年 | 748篇 |
2006年 | 779篇 |
2005年 | 735篇 |
2004年 | 755篇 |
2003年 | 712篇 |
2002年 | 712篇 |
2001年 | 118篇 |
2000年 | 81篇 |
1999年 | 142篇 |
1998年 | 147篇 |
1997年 | 117篇 |
1996年 | 109篇 |
1995年 | 84篇 |
1994年 | 79篇 |
1993年 | 88篇 |
1992年 | 45篇 |
1991年 | 49篇 |
1990年 | 40篇 |
1989年 | 41篇 |
1988年 | 28篇 |
1987年 | 28篇 |
1986年 | 26篇 |
1985年 | 15篇 |
1984年 | 15篇 |
1983年 | 10篇 |
1982年 | 16篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 10篇 |
1978年 | 10篇 |
1977年 | 8篇 |
1976年 | 6篇 |
1974年 | 3篇 |
1972年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
Hideki Watanabe Hiromi Hamada Yutaka Fujiki Sawako Takeuchi Kuni Urushigawa Hiroyuki Yoshikawa 《Hypertension in pregnancy》2006,25(1):33-35
Visual disturbances occur more frequently during preeclampsia than during pregnancy in general, but visual disturbances due to cranial nerve palsy are rare. We present the case of a 35-year-old preeclamptic woman with left third nerve palsy and left serous retinal detachment. The patient complained of visual disturbance and double vision soon after cesarean section. Left third nerve palsy and left serous retinal detachment were diagnosed by urgent ophthalmologic evaluation. Aneurysm and organic brain lesion were ruled out by diagnostic imaging. By 2 months postpartum, the visual disturbance had improved spontaneously. 相似文献
82.
Tetsuya Mitsudomi Takayuki Kosaka Hideki Endoh Yoshitsugu Horio Toyoaki Hida Shoichi Mori Shunzo Hatooka Masayuki Shinoda Takashi Takahashi Yasushi Yatabe 《Journal of clinical oncology》2005,23(11):2513-2520
PURPOSE: To evaluate the relationship between mutations of the epidermal growth factor receptor (EGFR) gene and the effectiveness of gefitinib treatment in patients with recurrent lung cancer after pulmonary resection. PATIENTS AND METHODS: We sequenced exons 18-21 of the EGFR gene using total RNA extracted from 59 patients with lung cancer who were treated with gefitinib for recurrent lung cancer. Gefitinib effectiveness was evaluated by both imaging studies and change in serum carcinoembryonic antigen (CEA) levels. RESULTS: EGFR mutations were found in 33 patients (56%). Of these mutations, 17 were deletions around codons 746-750 and 15 were point mutations (12 at codon 858, three at other codons), and one was an insertion. EGFR mutations were significantly more prevalent in females, adenocarcinoma, and never-smokers. Gefitinib treatment resulted in tumor shrinkage and/or CEA decrease to less than half of the baseline level in 26 patients, tumor growth and/or CEA elevation in 24 patients, and gefitinib effect was not assessable in nine patients. Female, never-smoking patients with adenocarcinoma tended to respond better to gefitinib treatment. Gefitinib was effective in 24 of 29 patients with EGFR mutations, compared with two of 21 patients without mutations (P < .0001). Of note, del746-750 might be superior to L858R mutations for prediction of gefitinib response. Patients with EGFR mutations survived for a longer period than those without the mutations after initiation of gefitinib treatment (P = .0053). CONCLUSION: EGFR mutations were a good predictor of clinical benefit of gefitinib in this setting. 相似文献
83.
Kousaku Mimura Koji Kono Mitsuhiko Hanawa Mirei Kanzaki Atsuhito Nakao Akishi Ooi Hideki Fujii 《Clinical cancer research》2005,11(13):4898-4904
PURPOSE: In the present study, we investigated the degree of protein expression and gene amplification of HER-2 in esophageal squamous cell carcinoma (SCC) cell lines and freshly isolated tumors, and trastuzumab-mediated biological activity, in particular antibody-dependent cellular cytotoxicity (ADCC) against HER-2-expressing esophageal SCC cell lines. EXPERIMENTAL DESIGN: Ten different SCC cell lines with various levels of HER-2 status evaluated by flow cytometry, immunocytochemistry (HercepTest), and fluorescence in situ hybridization were evaluated for ADCC, growth inhibitory, or apoptosis-inducing activities mediated by trastuzumab. RESULTS: Trastuzumab induced ADCC against HER-2-expressing esophageal SCC and the activities reflected the degree of HER-2 expression analyzed by flow cytometric analysis, but not by HercepTest nor fluorescence in situ hybridization analysis. Furthermore, trastuzumab-mediated ADCC against transforming growth factor-beta-producing SCC was enhanced by the treatment with SB-431542, which is a selective inhibitor of the phosphorylation induced by transforming growth factor-beta. There were very marginal effects of anti-proliferative or apoptosis-inducing activities mediated by trastuzumab for HER-2-expressing esophageal SCC. CONCLUSION: HER-2-expressing esophageal SCC cells could be killed by trastuzumab-mediated ADCC and the activity reflected the degree of HER-2 expression detected by flow cytometry. 相似文献
84.
Toshimitsu Tanaka Hiroyuki Suzuki Keisuke Miwa Tomoyuki Ushijima Sachiko Nagasu Masaru Fukahori Kaito Ishii Toru Nakamura Hideki Iwamoto Atsutaka Masuda Takahiko Sakaue Hironori Koga Yoshito Akagi Kenta Murotani Takuji Torimura 《Oncology Letters》2022,24(3)
Trousseau syndrome-related cerebral infarction rarely occurs during chemotherapy in patients with gastrointestinal (GI) cancer, and its clinical features remain unclear. The present study aimed to examine the clinical features of Trousseau syndrome-related cerebral infarction developed during chemotherapy for GI cancer. The present retrospective cohort study consecutively enrolled 878 patients with unresectable GI cancer who received chemotherapy at the Multidisciplinary Treatment Cancer Center, Kurume University Hospital (Kurume, Japan) between April 2014 and March 2020. Patients with colorectal cancer (n=308) were the most common, followed by those with pancreatic (n=242), gastric (n=222) and biliary tract (n=59) cancer, neuroendocrine tumors (n=34) and duodenal cancer (n=11). Among the 878 patients, Trousseau syndrome-related cerebral infarction occurred in 8 (0.9%) patients with a median age of 70.5 years (range, 58–75 years), and 50% of the patients were male (4/8). In total, 3 patients had gastric cancer, 3 had pancreatic cancer and 2 had biliary tract cancer. A greater percentage of patients with Trousseau syndrome-related cerebral infarction had hyperlipidemia (38.0%) than those without (8.2%; P=0.005). Hyperlipidemia was a risk factor for occurrence of Trousseau syndrome-related cerebral infarction with an odds ratio of 7.009 (95% confidence interval, 1.785-27.513). Trousseau syndrome-related cerebral infarction developed during GI chemotherapy was rare and hyperlipidemia may predict its onset. 相似文献
85.
T‐cell‐rich HLA‐haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome‐positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy 下载免费PDF全文
Hideki Sano Kazuhiro Mochizuki Mitsuko Akaihata Shogo Kobayashi Hitoshi Ohto Atsushi Kikuta 《Pediatric blood & cancer》2017,64(3)
Intensive chemotherapy with tyrosine kinase inhibitor (TKI) improves the prognosis of patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐ALL). However, the prognosis of cases of relapsed or refractory Ph‐ALL remains poor. Here, we aimed to assess the efficacy of T‐cell‐rich HLA‐haploidentical hematopoietic stem cell transplantation (TCR‐haplo‐HSCT) in eight patients with relapsed or refractory pediatric Ph‐ALL. Transplant‐related mortality was observed in two patients. All patients discontinued TKI after receiving TCR‐haplo‐HSCT. The 3‐year probability of overall survival and event‐free survival was 75.0 and 62.5%, respectively. These results indicate the efficacy of TCR‐haplo‐HSCT for relapsed/refractory pediatric Ph‐ALL. 相似文献
86.
The relationship between intraocular pressure and refractive error adjusting for age and central corneal thickness 总被引:19,自引:0,他引:19
Hideki Nomura Fujiko Ando Naoakira Niino Hiroshi Shimokata Yozo Miyake 《Ophthalmic & physiological optics》2004,24(1):41-45
PURPOSE: To investigate the relationship between intraocular pressure (IOP) and refractive errors after adjusting for age, central corneal thickness (CCT), and other related factors. METHODS: IOP, CCT and refractive errors were measured in the right eyes of 1855 subjects, aged 40-82 years, in a cross-sectional study design. Subjects were divided into groups by refractive status: hyperopia, emmetropia, mild myopia, moderate myopia, or high myopia. With adjustments for age, CCT, blood pressure, obesity, education, hypertension, diabetes, and smoking status, IOP was estimated for each refractive status using a general linear model. RESULTS: IOP increased with advancing degrees of myopia, even after adjustment for age, CCT, and other related factors (p = 0.011). Estimated IOP of moderate myopia was significantly higher than that of emmetropia (p = 0.022). CONCLUSIONS: Our results confirm the positive association between IOP and increasing degrees of myopia. This finding would support the hypothesis that the relationship between glaucoma and myopia might be pressure mediated. 相似文献
87.
Toshinori Tsuruta Chunyan Yang Hiroshi Ueki Guangying Li Akiko Maekawa Hideki Kamikawa Eisaku Oku Takao Somehara Hiroshi Fujito Hideharu Tatebayashi Shigeto Yamada 《Nihon shinkei seishin yakurigaku zasshi》2007,27(1):9-12
A rapid and sensitive high-performance liquid chromatographic method was validated and described for determination of paroxetine in human saliva. Following liquid-liquid extraction of the drug and an internal standard (dibucaine), chromatographic separation was accomplished using a C18 analytical column with a mobile phase consisting of 0.05 mol/L sodium phosphate buffer, pH 5.0, and acetonitrile (A 30:70, v/v; B 60:40, v/v). Paroxetine and the internal standard were detected by ultraviolet absorbance at 205 nm. The average recoveries of the drug and internal standard were 92.5% and 89%, respectively. The lower limits of detection and quantification were 1 and 4 ng/ml, respectively, and the calibration curve was linear over a concentration range of 4 ng/ml. The saliva level of paroxetine in patients with depression taking 10 to 40 mg/day of the drug was significantly correlated with the plasma level of paroxetine in each patient (r = 0.617, P < 0.004, n = 19). These data indicate that the saliva level of paroxetine could be a useful marker to predict the plasma level of the drug. 相似文献
88.
89.
Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages 总被引:2,自引:0,他引:2
Noguchi S Nakatsuka M Konishi H Kamada Y Chekir C Kudo T 《International immunopharmacology》2003,3(9):1335-1344
Nafamostat mesilate (NM), a clinically used serine protease inhibitor, suppressed the overproduction of nitric oxide (NO) and the expression of inducible nitric oxide synthase (iNOS) in RAW264.7 murine macrophages treated with lipopolysaccharide (LPS, 100 ng/ml); however, it had little effect on endothelial NOS (eNOS) in human umbilical vein endothelial cells (HUVEC). Electrophoretic mobility shift assay (EMSA) revealed that LPS activated nuclear factor-kappaB (NF-kappaB) in RAW264.7 cells and that this activation was suppressed by nafamostat mesilate. Western blotting showed that nafamostat mesilate suppressed the phosphorylation and degradation of inhibitor kappaB-alpha (IkappaB-alpha), which holds NF-kappaB in the cytoplasm in an inactivated state. Our observations suggest that nafamostat mesilate is a candidate agent for various diseases such as ischemia-reperfusion, graft rejection, inflammatory diseases, and autoimmune diseases, in which iNOS and/or NF-kappaB are upregulated. 相似文献